The Latest in Psoriatic Arthritis

Dermatology News

How to make the most of your time with psoriasis patients

February 9, 2022

Severe Acute Systemic Reaction After the First Injections of Ixekizumab

February 2, 2022

Dermatology News

A dermatologist-led model for CVD prevention in psoriasis may be feasible

February 1, 2022

Dermatology News

FDA approves risankizumab (Skyrizi) for psoriatic arthritis

January 27, 2022

Psoriatic Arthritis

Dermatology News

More frequent secukinumab dosing found to benefit overweight psoriasis patients

January 26, 2022

Dermatology News

Proactive infliximab monitoring found best for sustaining control of inflammatory diseases

January 10, 2022

Dermatology News

Case series show no consensus on treatment for palmoplantar pustulosis, generalized pustular psoriasis

January 4, 2022

Dermatology News

Spesolimab speeds lesion clearance in generalized pustular psoriasis

December 27, 2021

Dermatology News

New option for flares in pustular psoriasis

December 17, 2021

Dermatology News

Upadacitinib (Rinvoq) gains psoriatic arthritis as second FDA-approved indication

December 15, 2021

Psoriatic Arthritis

Dermatology News

Guselkumab’s efficacy, safety confirmed in patients with psoriatic arthritis and prior TNFi exposure

December 2, 2021

TNF-α inhibitor remains a promising therapy for nail psoriasis and concomitant PsA

November 30, 2021

Psoriatic Arthritis

Upadacitinib improves PRO in PsA patients with inadequate response to non-bDMARD

November 30, 2021

Psoriatic Arthritis

Risk for PsA looms in psoriasis despite treatment with biologics

November 30, 2021

Psoriatic Arthritis

No impact of COVID-19 pandemic on prevalence of depressive symptoms in patients with PsA

November 30, 2021

Psoriatic Arthritis